CLINICAL CHARACTERISTICS OF PATIENTS CLASSIFIED AS VERY HIGH RISK AND NOT VERY HIGH RISK BASED ON THE 2018 AHA/ACC MULTI-SOCIETY CHOLESTEROL GUIDELINE

Aparna Sajja; Amir Ali; Hsin-Fang Li; Kateri Spinelli; Salim S. Virani; Seth Shay Martin; Tyler J. Gluckman

doi:10.1016/S0735-1097(20)32538-9

CLINICAL CHARACTERISTICS OF PATIENTS CLASSIFIED AS VERY HIGH RISK AND NOT VERY HIGH RISK BASED ON THE 2018 AHA/ACC MULTI-SOCIETY CHOLESTEROL GUIDELINE

Aparna Sajja, Amir Ali, Hsin-Fang Li, Kateri Spinelli, Salim S. Virani, Seth Shay Martin, Tyler J. Gluckman

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of the American College of Cardiology
Volume	75
DOIs	https://doi.org/10.1016/S0735-1097(20)32538-9
State	Published - Mar 16 2020

Disciplines

Endocrinology, Diabetes, and Metabolism
Cardiology
Internal Medicine
Medicine and Health Sciences

Access to Document

10.1016/S0735-1097(20)32538-9License: Unspecified

Cite this

@article{31fe897ccd724af8baf9a332806b9b01,

title = "CLINICAL CHARACTERISTICS OF PATIENTS CLASSIFIED AS VERY HIGH RISK AND NOT VERY HIGH RISK BASED ON THE 2018 AHA/ACC MULTI-SOCIETY CHOLESTEROL GUIDELINE",

author = "Aparna Sajja and Amir Ali and Hsin-Fang Li and Kateri Spinelli and Virani, {Salim S.} and Martin, {Seth Shay} and Gluckman, {Tyler J.}",

note = "The 2018 AHA/ACC Cholesterol Guideline recommendation to classify ASCVD patients as very high-risk (VHR) vs not-VHR (NVHR) has important implications for ezetimibe and PCSK9 inhibitor eligibility. We aimed to define the clinical characteristics of these two groups within a large multi-state",

year = "2020",

month = mar,

day = "16",

doi = "10.1016/S0735-1097(20)32538-9",

language = "American English",

volume = "75",

journal = "Journal of the American College of Cardiology",

}

TY - JOUR

T1 - CLINICAL CHARACTERISTICS OF PATIENTS CLASSIFIED AS VERY HIGH RISK AND NOT VERY HIGH RISK BASED ON THE 2018 AHA/ACC MULTI-SOCIETY CHOLESTEROL GUIDELINE

AU - Sajja, Aparna

AU - Ali, Amir

AU - Li, Hsin-Fang

AU - Spinelli, Kateri

AU - Virani, Salim S.

AU - Martin, Seth Shay

AU - Gluckman, Tyler J.

N1 - The 2018 AHA/ACC Cholesterol Guideline recommendation to classify ASCVD patients as very high-risk (VHR) vs not-VHR (NVHR) has important implications for ezetimibe and PCSK9 inhibitor eligibility. We aimed to define the clinical characteristics of these two groups within a large multi-state

PY - 2020/3/16

Y1 - 2020/3/16

UR - https://www.onlinejacc.org/content/75/11_Supplement_1/1911

U2 - 10.1016/S0735-1097(20)32538-9

DO - 10.1016/S0735-1097(20)32538-9

M3 - Article

VL - 75

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

ER -

CLINICAL CHARACTERISTICS OF PATIENTS CLASSIFIED AS VERY HIGH RISK AND NOT VERY HIGH RISK BASED ON THE 2018 AHA/ACC MULTI-SOCIETY CHOLESTEROL GUIDELINE

Disciplines

Access to Document

Other files and links

Cite this